Interleukin-6 Receptor Inhibitor Sarilumab in Combination With Ipilimumab, Nivolumab and Relatlimab in Patients With Unresectable Stage III or Stage IV Melanoma
- Status
- RECRUITING
- Phase
- PHASE2
Clinical Trials Related to Melanoma
Related studies linked through entity extraction aliases.
Exploratory Interventional Study of Prognostic Serum Biomarkers of Cancer Progression
- Status
- UNKNOWN
- Phase
- NA
A Study of TRK-950 in Patients With Advanced Solid Tumors
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
A Study of Multiple Doses of RO7247669 in Participants With Previously Untreated Unresectable or Metastatic Melanoma
- Status
- COMPLETED
- Phase
- PHASE2
Cryoablation Combined With Tislelizumab Plus Lenvatinib in Patients With Melanoma Liver Metastasis
- Status
- UNKNOWN
- Phase
- PHASE2
Marathon of Hope Cancer Centres Network Study for Ontario (MOHCCN-O)
- Status
- RECRUITING
- Phase
- N/A
Clinical Outcomes and Biomarkers in Patients With Stage 0-IV Melanoma in Real Clinical Practice
- Status
- UNKNOWN
- Phase
- N/A
Intra-Lymphatic STI-3031 Using the Sofusa DoseConnect Device for Treatment of In-Transit Melanoma, The Sofusa-2 Study
- Status
- TERMINATED
- Phase
- PHASE1
Education for Prevention of Melanoma in Hispanic Populations
- Status
- TERMINATED
- Phase
- PHASE2
MySmartSkin Online Skin Self-exam Intervention for Melanoma Survivors
- Status
- RECRUITING
- Phase
- NA
The Impact of a Prevention Program on Sun Risks in Primary School in Tropical French Region
- Status
- COMPLETED
- Phase
- NA
A Clinical Study of LM103 Injection in the Treatment of Advanced Solid Tumors
- Status
- RECRUITING
- Phase
- PHASE1
A Study to Learn About the Study Medicine Called PF-07799933 in People With Advanced Solid Tumors With BRAF Alterations.
- Status
- RECRUITING
- Phase
- PHASE1
A First-in-human (FIH) Combination Treatment Study With a Single Dose Level of BMC128
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1
Clinical Study of Fianlimab in Combination With Cemiplimab Versus Pembrolizumab in Adolescent and Adult Patients With Previously Untreated Unresectable Locally Advanced or Metastatic Melanoma
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE3
NAUTILUS: OKI-179 Plus Binimetinib in Patients with Advanced Solid Tumors in the RAS Pathway (Phase 1b) and NRAS-mutated Melanoma (Phase 2)
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Ex-vivo Examination of Excisions of Skin Tumors by Confocal Optical Coherence Tomography (LC-OCT) With Integrated Dermoscopy and Comparison With Histology (DERMOCTAV)
- Status
- UNKNOWN
- Phase
- N/A
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
- Status
- RECRUITING
- Phase
- N/A
Study of NGM438 as Monotherapy and in Combination With Pembrolizumab in Advanced or Metastatic Solid Tumors
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1
Neoadjuvant Dual Checkpoint Inhibition and Cryoablation in Relapsed/Refractory Pediatric Solid Tumors
- Status
- COMPLETED
- Phase
- PHASE2